Genetics in ischaemic heart disease;Genetyczne uwarunkowanie choroby niedokrwiennej serca

Polski Merkuriusz Lekarski

Volumn 23, Issue 133, 2007, Pages 5-8

  Wojtczak, Anna ^a   Skretkowicz, Jadwiga ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Genetic polymorphism; Ischaemic hart disease

Indexed keywords

ARTICLE; BLOOD CLOTTING; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; LIPID METABOLISM; MUSCLE DEVELOPMENT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

BLOOD COAGULATION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; LIPID METABOLISM; MUSCLE DEVELOPMENT; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 34547771733     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Agerholm-Larsen B., Nordest B. G., Steffensen R. i wsp.: Elevated HDL cholesterol is a risk factor for ischaemic heart disease in white women when cause by common mutation in the cholesteryl ester transfer protein. Circulation, 2000, 101, 1907-1912.
2. Anderson J.L., Muhlestein J.B., Habashi J. i wsp.: Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction. J. Am. Coll. Cardiol., 1999, 34, 1778-1783.
3. Antonicelli R., Olivieri F., Bonafe M. i wsp.: The interleukin-6 -174 G>C promoter polymorphism is associated with a higher risk of death after an acute coronary syndrome in male elderly patients. Int. J. Cardiol., 2005, 103(3), 266-271.
4. Ardissino D., Mannucci P.M., Merlini P.A. i wsp.: Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood, 1999, 94, 46-51.
5. Aviram M., Billecke S., Sorenson R. i wsp.: Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from required for its arylesterase/paraoxynase activities: selective action of human paraoxynase allozymes Q and R. Arterioscler. Thromb. Vase. Biol., 1998, 18, 1617-1624.
6. Behague I., Poirier O., Nicaud V. i wsp.: Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM study. Circulation, 1996, 93, 440-449.
7. Berge K.E., Bakken A., Bohn M. i wsp.: A DNA polymorphism at the angiotensin Il type 1 receptor (AT1R) locus and myocardial infarction. Clin. Genet., 1997, 52, 71-76.
8. Biasucci L.M., Angiolillo D.J., Pignatti P.F. i wsp.: Interleukin-6 G174C polymorphism is associated with occurrence of unstable angina and with in vitro increased monocyte production of interleukin-6 in unstable patients. J. Am. Coll. Cardiol., 2001, 37, 314A.
9. Cambien F., Poirier O., Lecerf L. i wsp.: Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature, 1992, 359, 641-644.
10. Carter A.M., Ostranssei-Gerning N., Grant P.J.: Platelet glycoprotein Illa PIA polymorphism in young men with myocardial infarction. Lancet, 1996, 348, 485-486.
11. Ciechanowicz A., Januszewicz A., Januszewicz W., Rużytto W. (red.): Genetyka chorob uktadu kra̧żenia, Medycyna Praktyczna, Kraków 2002.
12. Eriksson P., Kallin B., Hooft F.M. i wsp.: Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc. Natl. Acad. Sci. USA, 1995, 92, 18511855.
13. Fang L., Wei H., Chowdhury S.H. i wsp.: Association of Leu125VaI polymorphism of platelet endothelial cell adhesion molecule-1 (PECAM-1) gene & soluble level of PECAM-1 with coronary artery disease in Asian Indians. Indian. J. Med. Res., 2005, 121(2), 92-99.
14. Fan Y.M., Salonen J.T., Koivu T.A. i wsp.: Hepatic lipase C-480T polymorphism modifies the effect of HDL cholesterol on the risk of acute myocardial infarction in men: a prospective population based study. J. Med. Genet., 2004, 41, 28-31.
15. Incalcaterra E., Hoffmann E., Averna M. R. i wsp.: Genetic risk factors in myocardial infarction at young age. Minerva. Cardioangiol., 2004, 52, 4, 287-312.
16. Jeunemaitre X., Ledru F, Battaglia S. i wsp.: Genetic polymorphism of the rennin-angiotensin system and angiographic Entent and severity of coronary artery disease: the CORGENE study. Hum. Genet., 1997, 99, 66-73.
17. Johnson J.A., Cavallari L.H.: Cardiovascular pharmacogenomics. Experimental Physiology, 2005, 90, 3, 283-289.
18. Koch W., Kastrati A., Bottiger C. i wsp.: Interleukin 10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis, 2001, 159, 137-144.
19. Kuivenhoven J.A., Jukema J.W., Zwinderman A.H. i wsp.: The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. N. Engl. J. Med., 1998, 338, 86-93.
20. Li Y, Wei Y.S., Wang M. i wsp.: Association between the Ser128Arg variant of the E-selectin and risk of coronary artery disease in the central China. Int. J. Cardiol., 2005, 103(1), 33-36.
21. Moshfegh K., Wuillemin W.A., Redondo M. i wsp.: Association of two silent polymorphisms of platelet glycoprotein la/lla receptor with risk of myocardial infarction: a case-control study. Lancet, 1999, 353, 351-354.
22. Ossei-Gerning N., Mansfield M.W., Stickland M.H. i wsp.: Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in rela-tion to a history of myocardial infarction in patients characterized by coronary angiography. Arterioscler. Thromb. Vase. Biol., 1997, 17, 33-37.
23. Plutzky J.: Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am. J. Cardiol., 2001, 88, 10-15.
24. Rauchhaus M., Gross M., Schulz S. i wsp.: The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty. Int. J. Cardiol., 2002, 83(3), 249-257.
25. Rigat B., Hubert C., Alhenc-Gelas F. i wsp.: An insertion/deletion polymorphism in the angiotensin I- converting enzyme gene accounting for half a variance of serum enzyme levels. J. Clin. Invest., 1990, 86, 1343-1346.
26. Rundek T., Elkind M.S., Pittman J. i wsp.: Carotid intima-media thickness is associated with allelic variants of stromelysin-1, interleukin-6, and hepatic lipase genes: the Northern Manhattan Prospective Cohort Study. Stroke, 2002, 33, 1420-1423.
27. Sie M.P., Uitterlinden A.G., Bos M.J. i wsp.: TGF-beta1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam Study. Stroke, 2006, 37(11), 2667-2671.
28. Sposito A.C., Gonbert S., Turpin G. i wsp.: Common promoter C516T polymorphism in the ApoB gene is an independent predictor of carotid atherosclerotic disease in subjects presenting a broad range of plasma cholesterol levels. Arterioscler. Thromb. Vase. Biol., 2004, 24(11), 2192-2195.
29. Teh L.K., Zilfalil B.A., Marina I. i wsp.: Genetic polymorphism of CYP2D6 in patients with cardiovascular disease - a cohort study. J. Clin. Pharm. Ther., 2004, 29, 559-564.
30. Tiret L., Bonnardeaux A., Poirier O. i wsp.: Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphism on risk of myocardial infarction. Lancet, 1994, 344, 910-913.
31. Tybjaerg-Hansen A., Agerholm-Larsen B., Humphries S.E. i wsp.: A common mutation (G-455 A) in the β-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischaemic heart disease. J. Clin. Invest., 1997, 99, 3034-3039.
32. Wittrup H.H., Tybjoerk-Hansen A., Abildgaard S. i wsp.: A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischaemic heart disease. J. Clin. Invest., 1997, 99, 1606-1613.
33. Ye S.Q., Usher D., Virgil D. i wsp.: A Pstl polymorphism detects the mutation of serine128 to arginine in CD 62E gene - a risk factor for coronary artery disease. J. Biomed. Sci., 1999, 6(1), 18-21.
34. Yokota M., Ichihara S., Lin T.L. i wsp.: Association of a T29-C polymorphism of the transforming growth factor-β1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation, 2000, 101, 2783-2787.
35. Yoshida M., Takano Y., Sasaoka T. i wsp.: E-selectin polymorphism associated with myocardial infarction causes enhanced leukocyte-endothelial interactions underflow conditions. Arterioscler. Thromb. Vase. Biol., 2003, 23(5), 783-788.
36. Zheng F., Chevalier J.A., Zhang L.Q. i wsp.: An Hphl polymorphism in the E-selectin gene is associated with premature coronary artery disease. Clin. Genet., 2001, 59(1), 58-64.